乐鱼在线
About Henlius
Company Profile
Corporate Culture
Honor
乐鱼在线:Board of Directors
Management Team
乐鱼在线:Advisory Committee
Product
乐鱼在线:Marketed Products
乐鱼在线:Products in R&D
乐鱼在线:Clinical Trial
Science & Technology
乐鱼在线:R&D Result
Innovation Centre
乐鱼在线:Technology Platform
Quality Management
Manufacturing
乐鱼在线:Collaborations
乐鱼在线:Investor Relations
Information Disclosure
Corporate Governance
Financial Reports
乐鱼在线:Stock Info
乐鱼在线:IR Calendar
Investor Presentation
乐鱼在线:Analyst Coverage
乐鱼在线:Contact Information
Media
乐鱼在线:Press Release
Multi-media
Media Reports
Media Enquiry
Careers
乐鱼在线:Talent Philosophy
乐鱼在线:Staff Life
乐鱼在线:Training and Development
Contact Us
乐鱼在线:Contact Information
乐鱼在线:Customer Message
Privacy
Legal Statement
Compliance
EN
简体
EN
繁體
Home
About Henlius
Company Profile
乐鱼在线:Corporate Culture
Honor
Board of Directors
乐鱼在线:Management Team
Advisory Committee
Product
Marketed Products
Products in R&D
Clinical Trial
Science & Technology
乐鱼在线:R&D Result
乐鱼在线:Innovation Centre
Technology Platform
Quality Management
Manufacturing
Collaborations
乐鱼在线:Investor Relations
乐鱼在线:Information Disclosure
乐鱼在线:Listing Documents
乐鱼在线:Announcement & Circulars
Corporate Governance
乐鱼在线:Financial Reports
Stock Info
IR Calendar
乐鱼在线:Investor Presentation
乐鱼在线:Analyst Coverage
乐鱼在线:Contact Information
Media
乐鱼在线:Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
乐鱼在线:Multi-media
Company
Event
乐鱼在线:Popular Science
乐鱼在线:Media Reports
Media Enquiry
Careers
Talent Philosophy
乐鱼在线:Staff Life
Training and Development
乐鱼在线:Job Opportunities
Contact Us
乐鱼在线:Contact Information
乐鱼在线:Customer Message
Privacy
Legal Statement
乐鱼在线:Compliance
Be the most trusted biotech company
乐鱼在线:Press Release
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Multi-media
Company
Popular Science
乐鱼在线:Highlights
Download
乐鱼在线:Media Reports
乐鱼在线:Media Enquiry
2024-05-24
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
2024-05-22
The Supplemental Applications of HANDAYUAN(adalimumab injection) for the New Indications Approved by the NMPA
2024-05-21
Henlius to Release Latest Clinical Data of HLX22 at 2024 ESMO GI
2024-05-16
Henlius to Showcase at BIO 2024
2024-05-15
First Patient Dosed for MRCT Phase 3 Study on First-Line mCRC of Henlius Anti-PD-1 mAb Serplulimab
2024-05-14
Henlius lasofoxifene HLX78 IND Approved by NMPA
2024-05-10
Henlius Holds its first Scientific Advisory Board Meeting of 2024
2024-05-06
Henlius Dual HER2 Blockade Therapy Receives Phase 3 MRCT IND Approval from U.S. FDA
2024-04-29
Henlius maintained a positive momentum of development in Q1 2024, with impressive performances by core products
1
2
3
...
34
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"});
乐鱼在线官网-乐鱼在线
ufc下注官网_ufc竞猜平台【新版本下载】
ufc下注_ufc押注网站
ufc下注官网_ufc竞猜软件【注册登录】
天博APP-天博APP下载-天博APP官方网站